Lemnisca

Based in India, Lemnisca specializes in innovative biomanufacturing solutions that leverage circular economy principles and local resource utilization to transform low-value materials into marketable products. Lemnisca is a biomanufacturing company founded in 2025 and headquartered in Bangalore, India. The company focuses on developing advanced manufacturing systems utilizing biological processes. The company's founder has not been publicly disclosed.

In November 2025, Lemnisca raised an undisclosed amount of pre-seed funding from Theia Ventures and PointOne Capital. Lemnisca specializes in developing a new manufacturing system that emphasizes circular economic principles and local resource utilization. The core product offerings revolve around innovative manufacturing technologies that leverage biological processes to transform low-value materials into valuable products. By integrating modern computational intelligence, Lemnisca ensures that these biological systems operate reliably and efficiently, addressing the need for sustainable production solutions across various industries, including textiles, packaging, and consumer goods.

The company targets markets in North America, Europe, and select regions in Asia, providing solutions to a diverse client base including manufacturers, retailers, and sustainability-focused enterprises. Their approach not only reduces waste but also enhances the resilience of supply chains by fostering local production capabilities. Lemnisca's revenue model is structured around partnerships and direct sales with businesses seeking sustainable manufacturing solutions. Transactions typically involve B2B agreements where companies integrate Lemnisca's technologies into their production processes.

Revenue is generated through the sale of proprietary systems and ongoing service agreements that may include maintenance and software updates. Specific pricing models are tailored to individual client needs, encompassing various plans based on the scale of implementation and the complexity of the biological manufacturing systems employed. This structure allows Lemnisca to cater to a wide range of clients, ensuring that companies can adopt their solutions in a flexible and economically viable manner. In November 2025, Lemnisca raised an undisclosed amount of pre-seed funding led by Theia Ventures, with participation from PointOne Capital and an additional individual investor.

The funding will be utilized to expand its Bengaluru lab, advance its AI-based biomanufacturing platform, and begin initial pilot production. The company plans to focus on launching new products that capitalize on its innovative technologies while expanding its reach into North American, European, and select Asian markets.